The St. Jude Comprehensive Cancer Center (SJCCC) makes extensive use of both internal and external expertise to plan and evaluate its efforts to identify cures for all children with cancer and mitigate long term side effects for survivors. To this end the Center has both an External Advisory Board (EAB), and internal advisory board (Cancer Center Advisor Committee, CCAC). The EAB comprises a dedicated and experienced group of nine individuals who provide ongoing advice to the Center Director and other Senior Leaders of the Cancer Center to enhance the quality and the effectiveness of the SJCCC Programs and Shared Resources. During the past year, the guidance provided by the EAB has been especially useful as the Center went through a transition in Director. Many Planning and Evaluation functions for the Cancer Center are supported by institutional funds. All of the funds requested from the CCSG for Planning and Evaluation are specifically used to support the efforts of the EAB by funding travel expenses and providing honoraria for their hard work and dedication.

Public Health Relevance

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA021765-35
Application #
8634440
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-04-01
Project End
2019-02-28
Budget Start
2014-06-09
Budget End
2015-02-28
Support Year
35
Fiscal Year
2014
Total Cost
$70,718
Indirect Cost
$30,622
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Schulte, Fiona; Brinkman, Tara M; Li, Chenghong et al. (2018) Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study. Cancer 124:3596-3608
Wu, Gang; Fan, Liying; Edmonson, Michael N et al. (2018) Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping. RNA 24:1056-1066
Ganguly, Samit; Panetta, John C; Roberts, Jessica K et al. (2018) Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice. Drug Metab Dispos 46:1014-1022
Pinto, Emilia M; Hamideh, Dima; Bahrami, Armita et al. (2018) Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Acta Neuropathol 136:315-326
Upadhyaya, Santhosh A; McGee, Rose B; Wilky, Breelyn A et al. (2018) Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 65:e27030
Klosky, James L; Lehmann, Vicky; Flynn, Jessica S et al. (2018) Patient factors associated with sperm cryopreservation among at-risk adolescents newly diagnosed with cancer. Cancer 124:3567-3575
Gibson, Todd M; Mostoufi-Moab, Sogol; Stratton, Kayla L et al. (2018) Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 19:1590-1601
Coustan-Smith, Elaine; Song, Guangchun; Shurtleff, Sheila et al. (2018) Universal monitoring of minimal residual disease in acute myeloid leukemia. JCI Insight 3:
Walker, Breya; Conklin, Heather M; Anghelescu, Doralina L et al. (2018) Parent perspectives and preferences for strategies regarding nonsedated MRI scans in a pediatric oncology population. Support Care Cancer 26:1815-1824
Hanna, Jason A; Garcia, Matthew R; Lardennois, Alicia et al. (2018) PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene 37:1991-2007

Showing the most recent 10 out of 6764 publications